Log In
BCIQ
Print this Print this
 

olumacostat glasaretil (DRM01) (formerly QLT91382, VAL-001)

  Manage Alerts
Collapse Summary General Information
Company Dermira Inc.
DescriptionAcetyl-Coenzyme A carboxylase (ACAC; ACC) inhibitor
Molecular Target Acetyl-Coenzyme A carboxylase (ACAC) (ACC)
Mechanism of ActionAcetyl-Coenzyme A carboxylase (ACAC) (ACC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAcne
Indication DetailsTreat acne vulgaris; Treat moderate to severe facial acne vulgaris
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/24/2011

Undisclosed

Undisclosed

0

05/31/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today